Insulet Corporation Financials

Market Capitalization $21.23 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	54.35
Forward PE	77.94
Price to Sales TTM	$9.65
Price to Book MRQ	$15.95
Enterprise to Revenue	10.27
Enterprise to EBITDA	53.18

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	18.29%
Operating Margin	15.61%
Return on Assets TTM	6.94%
Return on Equity TTM	37.92%

Income Statement

Revenue TTM	$2,198,899,968
Revenue per Share TTM	$31.34
Quarterly Revenue Growth	28.80%
Gross Profit TTM	$1,547,900,032
EBITDA	$457,800,000
Net Income to Common TTM	$402,200,000
Diluted EPS TTM	$5.55
Quarterly Earnings Growth YoY	-31.30%

Balance Sheet

Total Cash MRQ	$1,283,100,032
Total Cash per Share MRQ	$18.23
Total Debt MRQ	$
Total Debt to Equity MRQ	131.41
Current Ratio MRQ	4.47
Book Value per Share MRQ	$18.91

Cash Flow

Operating Cash Flow TTM	$406,500,000
Levered Free Cash Flow TTM	$84,250,000

PODD Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	70,196,031
Float Shares	70,063,866
Avg 10 Volume	935,564
Avg 30 Volume	None
Shares Short	1,906,067
Short Ratio	2.27
Short % of Shares	4.12%
% Held by Insiders	0.29%
% Held by Institutions	102.55%

Stock Price Summary

Beta	1.38
Fifty Two Week Low	$173.00
Fifty Two Week High	$329.33
Fifty Two Week Change	34.60%
Day 50 MA	$297.54
Day 200 MA	$268.06

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date